PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
03-Oct-2024 ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities ProductLife Group
03-Oct-2024 MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme MitoRx Therapeutics
03-Oct-2024 Xcell Biosciences Expands AmplifyBio Collaboration with Unique Cell and Gene Therapy Manufacturing Capabilities Xcell Biosciences
03-Oct-2024 Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma Recursion
03-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
03-Oct-2024 Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board Curve Therapeutics
03-Oct-2024 First Clinical Data on Ornithine Transcarbamylase Deficiency Program to be presented at the European Society of Gene & Cell Therapy 31st Annual Meeting 2024 Bloomsbury Genetic Therapies Limited
03-Oct-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Janssen-Cilag International NV
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Helios Global Group, a leading full-service global healthcare communications provider, announces next stage of investment by Telemos Capital to support ambitious future growth Helios Global Group
01-Oct-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 AlzeCure's abstract on ACD856's anti-inflammatory effects to be presented at a leading Alzheimer's conference AlzeCure Pharma AB (publ)
01-Oct-2024 AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team AstronauTx Ltd
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals